摘要
目的:分析研讨托伐普坦联合小剂量多巴胺治疗顽固性心衰的临床效果。方法:2016年5月-2018年12月收治顽固性心衰患者60例,分为两组,各30例。对照组接受托伐普坦治疗;研究组接受托伐普坦联合小剂量多巴胺治疗。比较两组治疗状况。结果:研究组治疗总有效率优于对照组,研究组治疗后左室舒张末期容积(LEDV)、左室收缩末期容积(LESV)低于对照组,左室射血分数(LVEF)高于对照组,差异均有统计学意义(P<0.05)。结论:顽固性心衰患者接受托伐普坦联合小剂量多巴胺治疗,可显著改善其心功能,效果更良好。
Objective:To analyze the clinical effect of tovaptan combined with low dose dopamine in the treatment of refractory heart failure.Methods:60 patients with refractory heart failure were selected from May 2016 to December 2018,they were divided into the two groups with 30 cases in each group.The control group was treated with tovaptan,the study group was treated with tovaptan and low dose dopamine.The treatment status of the two groups was compared.Results:The total effective rate of the study group was better than that of the control group.After treatment,the LEDV and LESV of the study group were lower than those of the control group,and the LVEF was higher than that of the control group,the differences were statistically significant(P<0.05).Conclusion:The heart function of patients with refractory heart failure can be improved significantly and the effect is better when they are treated with tolvaptan and low dose dopamine.
作者
李萍
宋莉莉
宋书帅
李献良
崔美平
姜先雁
张彬
Li Ping;Song Lili;Song Shushuai;Li Xianliang;Cui Meiping;Jiang Xianyan;Zhang Bin(Department of Cardiology,Qingdao Fuwai Cardiovascular Hospital,Shandong Qingdao 266034)
出处
《中国社区医师》
2020年第11期44-44,46,共2页
Chinese Community Doctors
关键词
顽固性心衰
多巴胺
小剂量
托伐普坦
Intractable heart failure
Dopamine
Low dose
Tovaptan
